The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
The anticancer immune response: indispensable for therapeutic success?
Open accessAbstract
Although the impact of tumor immunology on the clinical management of most cancers is still negligible, there is increasing evidence that anticancer immune responses may contribute to the control of cancer after conventional chemotherapy. Thus, radiotherapy and some chemotherapeutic agents, in particular anthracyclines, can induce specific immune responses that result either in immunogenic cancer cell death or in immunostimulatory side effects. This anticancer immune response then helps to eliminate residual cancer cells (those that fail to be killed by chemotherapy) or maintains micrometastases in a stage of dormancy. Based on these premises, in this Review we address the question, How may it be possible to ameliorate conventional therapies by stimulating the anticancer immune response? Moreover, we discuss the rationale of clinical trials to evaluate and eventually increase the contribution of antitumor immune responses to the therapeutic management of neoplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bulanova, E., Budagian, V., Duitman, E. H., Orinska, Z., Krause, H., Rückert, R., Reiling, N., & Bulfone‐Paus, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610036200 · Cited by 63
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Self-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Self-citationDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Self-citationSwann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Adaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Dave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,418
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Ghiringhelli, F., Menard, C., Puig, P. E., Ladoire, S., Roux, S., Martin, F., Solary, E., Le Cesne, A., Zitvogel, L., & Chauffert, B. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0225-8 · Cited by 1,241
Self-citationCD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Gattinoni, L., Finkelstein, S. E., Klebanoff, C. A., Antony, P. A., Palmer, D. C., Spiess, P. J., Hwang, L. N., Yu, Z., Wrzesinski, C., Heimann, D. M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050732 · Cited by 1,061
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Self-citationLutsiak, M. E. C., Semnani, R. T., De Pascalis, R., Kashmiri, S. V. S., Schlom, J., & Sabzevari, H. (2005) · Blood · doi:10.1182/blood-2004-06-2410 · Cited by 903
Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., & Martin, F. (2004) · European Journal of Immunology · doi:10.1002/eji.200324181 · Cited by 880
Self-citationSerafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., & Borrello, I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061104 · Cited by 766
North, R. J. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.4.1063 · Cited by 650
Malignancy after Transplantation
Buell, J. F., Gross, T. G., & Woodle, E. S. (2005) · Transplantation · doi:10.1097/01.tp.0000186382.81130.ba · Cited by 595
Apetoh, L., Ghiringhelli, F., Tesniere, A., Criollo, A., Ortiz, C., Lidereau, R., Mariette, C., Chaput, N., Mira, J., Delaloge, S., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00573.x · Cited by 574
Self-citationLivingston, P. O., Wong, G. Y., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlon, C., Calves, M. J., Helling, F., & Ritter, G. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1036 · Cited by 516
Yu, J. S., Wheeler, C. J., Zeltzer, P. M., Ying, H., Nacis-Finger, D., Lee, P.-K., Yong, W. H., Incardona, F., Thompson, R. C., Riedinger, M. S., et al. (2001) · PubMed · Cited by 510
Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402201 · Cited by 474
Self-citationAntonia, S. J., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Bepler, G., Simon, G., Janssen, W., Lee, J.-H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2013 · Cited by 444
Chakraborty, M., Abrams, S. I., Coleman, C. N., Camphausen, K., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0073 · Cited by 435
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.
Nowak, A. K., Robinson, B. W. S., & Lake, R. (2003) · PubMed · Cited by 421
A novel dendritic cell subset involved in tumor immunosurveillance
Taieb, J., Chaput, N., Ménard, C., Apetoh, L., Ullrich, E., Bonmort, M., Péquignot, M., Casares, N., Terme, M., Flament, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1356 · Cited by 405
Self-citationAccelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination
Badovinac, V. P., Messingham, K. A. N., Jabbari, A., Haring, J. S., & Harty, J. T. (2005) · Nature Medicine · doi:10.1038/nm1257 · Cited by 402
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer
Mercader, M., Bodner, B. K., Moser, M. T., Kwon, P. S., Park, E. S. Y., Manecke, R. G., Ellis, T. M., Wojcik, E. M., Yang, D., Flanigan, R. C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251140998 · Cited by 393
Spisek, R., Charalambous, A., Mazumder, A., Vesole, D. H., Jagannath, S., & Dhodapkar, M. V. (2007) · Blood · doi:10.1182/blood-2006-10-054221 · Cited by 388
Danna, E. A., Sinha, P., Gilbert, M., Clements, V. K., Pulaski, B. A., & Ostrand-Rosenberg, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2646 · Cited by 371
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
Muranski, P., Boni, A., Wrzesinski, C., Citrin, D. E., Rosenberg, S. A., Childs, R., & Restifo, N. P. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0666 · Cited by 358
Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4252 · Cited by 358
Melani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z., & Colombo, M. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1882 · Cited by 329
Ladoire, S., Arnould, L., Apetoh, L., Coudert, B., Martin, F., Chauffert, B., Fumoleau, P., & Ghiringhelli, F. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4491 · Cited by 310
Self-citationBorg, C., Terme, M., Taïeb, J., Ménard, C., Flament, C., Robert, C., Maruyama, K., Wakasugi, H., Angevin, E., Thielemans, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21102 · Cited by 302
Berd, D., Maguire, H. C., McCue, P., & Mastrangelo, M. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1858 · Cited by 300
Rapoport, A. P., Stadtmauer, E. A., Aqui, N., Badros, A., Cotte, J., Chrisley, L., Veloso, E., Zheng, Z., Westphal, S., Mair, R., et al. (2005) · Nature Medicine · doi:10.1038/nm1310 · Cited by 290
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
Drake, C. G., Doody, A. D. H., Mihalyo, M. A., Huang, C.-T., Kelleher, E., Ravi, S., Hipkiss, E. L., Flies, D. B., Kennedy, E. P., Long, M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.027 · Cited by 289
Arlen, P. M., Gulley, J. L., Parker, C., Skarupa, L., Pazdur, M., Panicali, D., Beetham, P., Tsang, K. Y., Grosenbach, D. W., Feldman, J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2059 · Cited by 287
De Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., Del Soldato, P., Melani, C., Guiducci, C., Colombo, M. P., Iezzi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409783102 · Cited by 284
Augmentation of T cell levels and responses induced by androgen deprivation
Roden, A. C., Moser, M. T., Tri, S. D., Mercader, M., Kuntz, S. M., Dong, H., Hurwitz, A. A., McKean, D. J., Celis, E., Leibovich, B. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6098 · Cited by 276
Clinical Responsiveness of Glioblastoma Multiforme to Chemotherapy after Vaccination
Wheeler, C. J., Das, A., Liu, G., Yu, J. S., & Black, K. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0497 · Cited by 266
MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines
Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian‐Blander, J., & Barratt‐Boyes, S. M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00077.x · Cited by 261
Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors
Teague, R. M., Sather, B. D., Sacks, J. A., Huang, M. Z., Dossett, M. L., Morimoto, J., Tan, X., Sutton, S. E., Cooke, M. P., Öhlén, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1359 · Cited by 233
Taskinen, M., Karjalainen-Lindsberg, M.-L., Nyman, H., Eerola, L.-M., & Leppä, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0778 · Cited by 212
Ecto‐calreticulin in immunogenic chemotherapy
Obeid, M., Tesniere, A., Panaretakis, T., Tufi, R., Joza, N., Van Endert, P., Ghiringhelli, F., Apetoh, L., Chaput, N., Flament, C., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00567.x · Cited by 202
Self-citationSanda, M. G., Smith, D. C., Charles, L. G., Hwang, C., Pienta, K. J., Schlom, J., Milenic, D., Panicali, D., & Montie, J. E. (1999) · Urology · doi:10.1016/s0090-4295(98)00539-1 · Cited by 201
Fricke, I., Mirza, N., Dupont, J., Lockhart, C., Jackson, A., Lee, J.-H., Sosman, J. A., & Gabrilovich, D. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0409 · Cited by 182
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
Plate, J. M. D., Plate, A. E., Shott, S., Bograd, S., & Harris, J. E. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0638-1 · Cited by 176
Correale, P., Cusi, M. G., Tsang, K. Y., Del Vecchio, M. T., Marsili, S., Placa, M. L., Intrivici, C., Aquino, A., Micheli, L., Nencini, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.147 · Cited by 171
Page, S. T., Plymate, S. R., Bremner, W. J., Matsumoto, A. M., Hess, D. L., Lin, D. W., Amory, J. K., Nelson, P. S., & Wu, J. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00484.2005 · Cited by 170
Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer
Nesslinger, N. J., Sahota, R. A., Stone, B., Johnson, K., Chima, N., King, C., Rasmussen, D., Bishop, D., Rennie, P. S., Gleave, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1772 · Cited by 168
Gribben, J. G., Ryan, D. P., Boyajian, R., Urban, R. G., Hedley, M. L., Beach, K., Nealon, P., Matulonis, U., Campos, S., Gilligan, T. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2111 · Cited by 165
Halliday, G. M., Patel, A., Hunt, M. J., Tefany, F. J., & Barnetson, R. S. (1995) · World Journal of Surgery · doi:10.1007/bf00299157 · Cited by 162
MacLean, G. D., Miles, D. W., Rubens, R. D., Reddish, M. A., & Longenecker, B. M. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199607000-00006 · Cited by 161
Haanen, J. B. A. G., Baars, A., Gomez, R., Weder, P., Smits, M., de Gruijl, T. D., Blomberg, B. M. E. V., Bloemena, E., Scheper, R. J., van Ham, S. M., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0018-5 · Cited by 152
Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer
Goodell, V., Salazar, L. G., Urban, N. D., Drescher, C. W., Gray, H. J., Swensen, R. E., McIntosh, M. W., & Disis, M. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2813 · Cited by 149
Aragon‐Ching, J. B. (2007) · Frontiers in bioscience · doi:10.2741/2441 · Cited by 137
The DNA damage response, immunity and cancer
Gasser, S., & Raulet, D. H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.004 · Cited by 136
Development of antitumor immune responses in reconstituted lymphopenic hosts.
Hu, H., Poehlein, C. H., Urba, W. J., & Fox, B. A. (2002) · PubMed · Cited by 135
Castration alters peripheral immune function in normal male mice.
Viselli, S. M., Stanziale, S. F., Shults, K., Kovacs, W. J., & Olsen, N. J. (1995) · PubMed Central · Cited by 134
Höltl, L., Ramoner, R. E., Zelle‐Rieser, C., Gander, H., Putz, T., Papesh, C., Nußbaumer, W., Falkensammer, C. E., Bartsch, G. H., & Thurnher, M. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0629-2 · Cited by 132
Ge, Q., Hu, H., Eisen, H. N., & Chen, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052714099 · Cited by 127
Dendritic Cells Strongly Boost the Antitumor Activity of Adoptively Transferred T Cells In vivo
Lou, Y., Wang, G., Lizee, G. A., Kim, G. J., Finkelstein, S. E., Feng, C., Restifo, N. P., & Hwu, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1621 · Cited by 120
Orlando, L., Cardillo, A., Ghisini, R., Rocca, A., Balduzzi, A., Torrisi, R., Peruzzotti, G., Goldhirsch, A., Pietri, E., & Colleoni, M. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-225 · Cited by 119
Evans, R., Fuller, J. A., Christianson, G. J., Krupke, D. M., & Troutt, A. B. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1132 · Cited by 102
Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country
Sant, M., Capocaccia, R., Verdecchia, A., Estève, J., Gatta, G., Micheli, A., Coleman, M. P., Berrino, F., & The EUROCARE Working Group (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980831)77:5<720::aid-ijc10>3.0.co;2-5 · Cited by 97
Development and dynamics of robust T-cell responses to CML under imatinib treatment
Chen, C. I.-U., Maecker, H. T., & Lee, P. P. (2008) · Blood · doi:10.1182/blood-2007-12-128397 · Cited by 89
Schwartz, H. S., & Grindey, G. B. (1973) · PubMed · Cited by 83
Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy
Liu, G., Akasaki, Y., Khong, H. T., Wheeler, C. J., Das, A., Black, K. L., & Yu, J. S. (2005) · Oncogene · doi:10.1038/sj.onc.1208519 · Cited by 78
PML-RARA–targeted DNA vaccine induces protective immunity in a mouse model of leukemia
Padua, R. A., Larghero, J., Robin, M., Pogam, C. L., Schlageter, M., Muszlak, S., Frič, J., West, R., Rousselot, P. H., Phan, T. H., et al. (2003) · Nature Medicine · doi:10.1038/nm949 · Cited by 78
Elliott, B., Scolyer, R. A., Suciu, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0358 · Cited by 70
Adriamycin-induced modulation of host defenses in tumor-bearing mice.
Maccubbin, D., Wing, K. R., Mace, K. F., et al. (1992) · PubMed · Cited by 65
Weihrauch, M. R., Ansén, S., Jurkiewicz, E., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0018 · Cited by 65
Noguchi, M., Itoh, K., Yao, A., Mine, T., Yamada, A., Obata, Y., Furuta, M., Harada, M., Suekane, S., & Matsuoka, K. (2004) · The Prostate · doi:10.1002/pros.20157 · Cited by 58
Partial regression in primary carcinoma of the lung: does it occur?
Kerr, K. M., Johnson, S. K., King, G., Kennedy, M., Weir, J., & Jeffrey, R. R. (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00453.x · Cited by 55
Jones, R. C., Kelley, M., Gupta, R. K., Nizze, J. A., Yee, R., Leopoldo, Z. C., Qi, K., Stern, S. L., & Morton, D. L. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305761 · Cited by 53
Correale, P., Vecchio, M. T. D., Genova, G. D., Savellini, G. G., Placa, M. L., Terrosi, C., Vestri, M., Urso, R., Lemonnier, F. A., Aquino, A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji188 · Cited by 43
Bourquin, C., Schreiber, S. C., Beck, S., Hartmann, G., & Endres, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21681 · Cited by 42
D. –. G. C. R. C. C. T. G., Atzpodien, J., Kirchner, H. H., Rebmann, U., Soder, M., Gertenbach, U., Siebels, M., Roigas, J., Raschke, R., Salm, S., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603271 · Cited by 42
Bj, L., Lai, M., Cheng, L., Xu, J., & Huang, Q. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01998.x · Cited by 40
Kleinrath, T., Gassner, C., Lackner, P., Thurnher, M., & Ramoner, R. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8154 · Cited by 40
Levitt, M. L., Kassem, B. E. B., Gooding, W. E., Miketic, L. M., Landreneau, R. J., Ferson, P. F., Keenan, R., Yousem, S. A., Lindberg, C., Trenn, M. R., et al. (2003) · Lung Cancer · doi:10.1016/j.lungcan.2003.09.011 · Cited by 31
Hsueh, E. C., Gupta, R. K., Lefor, A. K., Reyzin, G., Ye, W., & Morton, D. L. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00005-2 · Cited by 26
Gołąb, J., Zagożdżon, R., Kozar, K., Kamiński, R., Giermasz, A., Stokłosa, T., Lasek, W., & Jakóbisiak, M. (2000) · Oncology Reports · doi:10.3892/or.7.1.177 · Cited by 13
Gold, J. E., Zachary, D. T., & Osband, M. E. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610424 · Cited by 12
Kasamon, Y. L., Flinn, I. W., Grever, M. R., Diehl, L. F., Garrett-Mayer, E. S., Goodman, S. N., Lucas, M. S., & Byrd, J. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1612 · Cited by 7
Cited by
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Self-citationDenkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Combining immunotherapy and targeted therapies in cancer treatment
Vanneman, M., & Dranoff, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3237 · Cited by 1,586
Metadata
- Authors
- Zitvogel, L., Apetoh, L., Ghiringhelli, F., André, F., Tesniere, A., & Kroemer, G.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-06-02
- Volume
- 118
- Issue
- 6
- Pages
- 1991-2001
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2083991703
- Cited by
- 573
- References
- 102
- FWCI
- 16.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.